ClinicalTrials.gg
Drug

Iguratimod clinical trials

Also written T-614.

studies test it
23
open now
7
in phase 3
2
first study started
2009

How each study uses iguratimod is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the iguratimod studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Iguratimod
19
Iremod
3
IGU
2

Development codes

T-614
5

Studies by the year they started

23 studies that test it; most in 2021 (5)

Studies that test iguratimod, by start year
YearStudies
20091
20123
20131
20162
20173
20201
20215
20224
20231
20241
20251

By phase

A phase 1/2 study counts in both.

Phase 1
2
Phase 2
8
Phase 3
2
Phase 4
10
No phase
4

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 6 · Other 17

Jiangsu Simcere Pharmaceutical Co., Ltd. (5) · Peking University People's Hospital (4) · Qilu Hospital of Shandong University (3) · RenJi Hospital (3) · Peking Union Medical College Hospital (2) · Eisai Co., Ltd. (1) · Nanfang Hospital, Southern Medical University (1) · Xuzhou Medical University (1)

Often tested with

Tested in the same studies.

Leflunomide (2) · Methotrexate (2) · T 614 (1) · Tofacitinib (1) · Glucocorticoid (1) · Adalimumab (1) · Hydroxychloroquine (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 2

Studies that test iguratimod.

Studies

Open first, then newest update. How each study uses iguratimod is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 23

See all 23 studies that test iguratimod →

Given beside what is tested · 1 — iguratimod is usual care or a partner of the new treatment

Codes

What other systems call iguratimod · ClinicalTrials.gg INT005072

  • MeSH (NLM) C519076iguratimodOne source NLM
  • UNII (FDA) 4IHY34Y2NVIGURATIMODConfirmed FDA, NLM, Wikidata
  • Wikidata Q13575264iguratimodConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C65886IguratimodOne source FDA
  • DrugBank DB12233One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.